CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size

Human Molecular Genetics

Volumn 23, Issue 12, 2014, Pages 3228-3238

  Ludwig, Anna Lisa ^a   Espinal, Glenda M ^a   Pretto, Dalyir I ^a,b   Jamal, Amanda L ^a   Arque, Gloria ^a   Tassone, Flora ^a,b   Berman, Robert F ^a,b   Hagerman, Paul J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CGG REPEAT SIZE; CONGENIC STRAIN; CONTROLLED STUDY; FRONTAL CORTEX; GENE EXPRESSION; GENETIC PARAMETERS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE; ANIMAL; ANTIBODY SPECIFICITY; DISEASE MODEL; FEMALE; FRAGILE X SYNDROME; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TRINUCLEOTIDE REPEAT;

ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; FRONTAL LOBE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MALE; MICE; ORGAN SPECIFICITY; RNA, MESSENGER; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84897370853     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu032     Document Type: Article

References (67)

1. Loesch, D.Z., Huggins, R.M. and Hagerman, R.J. (2004) Phenotypic variation and FMRP levels in fragile X. Ment. Retard. Dev. Disabil. Res. Rev., 10, 31-41.
2. Hagerman, R.J., Berry-Kravis, E., Kaufmann, W.E., Ono, M.Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J. et al. (2009) Advances in the treatment of fragile X syndrome. Pediatrics, 123, 378-390.
3. Schneider, A., Hagerman, R.J. and Hessl, D. (2009) Fragile X syndrome-from genes to cognition. Dev. Disabil. Res. Rev., 15, 333-342.
4. Pieretti, M., Zhang, F.P., Fu, Y.H., Warren, S.T., Oostra, B.A., Caskey, C.T. and Nelson, D.L. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66, 817-822.
5. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G. Jr, Warren, S.T. et al. (1991) Variation of theCGGrepeat at the fragileXsite results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047-1058.
6. Tassone, F., Iong, K.P., Tong, T.H., Lo, J., Gane, L.W., Berry-Kravis, E., Nguyen, D., Mu, L.Y., Laffin, J., Bailey, D.B. et al.. (2012) FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med., 4, 100.
7. Maenner, M.J., Baker, M.W., Broman, K.W., Tian, J., Barnes, J.K., Atkins, A., McPherson, E., Hong, J., Brilliant, M.H.and Mailick, M.R. (2013)FMR1 CGG expansions: prevalence and sex ratios. Am. J. Med. Genet. B Neuropsychiatr. Genet., 162B, 466-473.
8. Hantash, F.M., Goos, D.M., Crossley, B., Anderson, B., Zhang, K., Sun, W. and Strom, C.M. (2011) FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet. Med., 13, 39-45.
9. Hagerman, P. (2013) Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms. Acta Neuropathol., 126, 1-19.
10. Hagerman, R.J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B. and Hagerman, P.J. (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 57, 127-130.
11. Hagerman,P.J. andHagerman,R.J. (2004)FragileX-associated tremor/ataxia syndrome (FXTAS). Ment. Retard. Dev. Disabil. Res. Rev., 10, 25-30.
12. Leehey, M.A. and Hagerman, P.J. (2012) Fragile X-associated tremor/ataxia syndrome. Handb. Clin. Neurol., 103, 373-386.
13. Apartis, E., Blancher, A., Meissner, W.G., Guyant-Marechal, L., Maltete, D., De Broucker, T., Legrand, A.P., Bouzenada, H., Thanh, H.T., Sallansonnet-Froment, M. et al. (2012) FXTAS: new insights and the need for revised diagnostic criteria. Neurology, 79, 1898-1907.
14. Juncos, J.L., Lazarus, J.T., Graves-Allen, E., Shubeck, L., Rusin, M., Novak, G., Hamilton, D., Rohr, J. and Sherman, S.L. (2011) New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics, 12, 123-135.
15. Jacquemont, S., Hagerman, R.J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J.A., Greco, C., Des Portes, V., Jardini, T., Levine, R. et al. (2003) Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet., 72, 869-878.
16. Leehey, M.A., Legg, W., Tassone,F. and Hagerman,R. (2011) Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology, 50, 2233-2236.
17. Hunsaker, M.R., Greco, C.M., Spath, M.A., Smits, A.P., Navarro, C.S., Tassone, F., Kros, J.M., Severijnen, L.A., Berry-Kravis, E.M., Berman, R.F. et al. (2011) Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol., 122, 467-479.
18. Schwartz, C.E., Dean, J., Howard-Peebles, P.N., Bugge, M., Mikkelsen, M., Tommerup, N., Hull, C., Hagerman, R., Holden, J.J. and Stevenson, R.E. (1994) Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am. J. Med. Genet., 51, 400-402.
19. Sullivan, S.D., Welt, C. and Sherman, S. (2011) FMR1 and the continuumof primary ovarian insufficiency. Semin. Reprod. Med., 29, 299-307.
20. Tassone, F., Hagerman, R.J., Taylor, A.K., Gane, L.W., Godfrey, T.E. and Hagerman, P.J. (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet., 66, 6-15.
21. Kenneson, A., Zhang, F., Hagedorn, C.H. and Warren, S.T. (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet., 10, 1449-1454.
22. Tassone, F., Beilina, A., Carosi, C., Albertosi, S., Bagni, C., Li, L., Glover, K., Bentley, D. and Hagerman, P.J. (2007) Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA, 13, 555-562.
23. Allen, E.G., He, W., Yadav-Shah, M. and Sherman, S.L. (2004) A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum. Genet., 114, 439-447.
24. Peprah, E., He, W., Allen, E., Oliver, T., Boyne, A. and Sherman, S.L. (2010) Examination of FMR1 transcript and protein levels among 74 premutation carriers. J. Hum. Genet., 55, 66-68.
25. Primerano, B., Tassone, F., Hagerman, R.J., Hagerman, P., Amaldi, F. and Bagni, C. (2002) Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA, 8, 1482-1488.
26. Napierala, M., Michalowski, D., de Mezer, M. and Krzyzosiak, W.J. (2005) Facile FMR1 mRNA structure regulation by interruptions in CGG repeats. Nucleic Acids Res., 33, 451-463.
27. Zumwalt, M., Ludwig, A., Hagerman, P.J. and Dieckmann, T. (2007) Secondary structure and dynamics of the r(CGG) repeat in the mRNA of the fragile X mental retardation 1 (FMR1) gene. RNA Biol., 4, 93-100.
28. Jin, P., Zarnescu, D.C., Zhang, F., Pearson, C.E., Lucchesi, J.C., Moses, K. and Warren, S.T. (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron, 39, 739-747.
29. Arocena, D.G., Iwahashi, C.K.,Won, N., Beilina, A., Ludwig, A.L., Tassone, F.,Schwartz, P.H. andHagerman, P.J. (2005) Inductionof inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum. Mol. Genet., 14, 3661-3671.
30. Hashem, V., Galloway, J.N., Mori, M., Willemsen, R., Oostra, B.A., Paylor, R. and Nelson, D.L. (2009) Ectopic expression ofCGGcontainingmRNAis neurotoxic in mammals. Hum. Mol. Genet., 18, 2443-2451.
31. Garcia-Arocena, D., Yang, J.E., Brouwer, J.R., Tassone, F., Iwahashi, C., Berry-Kravis, E.M., Goetz, C.G., Sumis, A.M., Zhou, L., Nguyen, D.V. et al. (2010) Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum. Mol. Genet., 19, 299-312.
32. Berman, R.F., Murray, K.D., Arque, G., Hunsaker, M.R. and Wenzel, H.J. (2012) Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation. Epilepsia, 53(Suppl 1), 150-160.
33. Brouwer, J.R., Huizer, K., Severijnen, L.A., Hukema, R.K., Berman, R.F., Oostra, B.A. and Willemsen, R. (2008) CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J. Neurochem., 107, 1671-1682.
34. Brouwer, J.R., Mientjes, E.J., Bakker, C.E., Nieuwenhuizen, I.M., Severijnen, L.A., Van der Linde, H.C., Nelson, D.L., Oostra, B.A. and Willemsen, R. (2007) Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp. Cell Res., 313, 244-253.
35. Brouwer, J.R., Severijnen, E., de Jong, F.H., Hessl, D., Hagerman, R.J., Oostra, B.A. and Willemsen, R. (2008) Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology, 33, 863-873.
36. Entezam, A., Biacsi, R., Orrison, B., Saha, T., Hoffman, G.E., Grabczyk, E., Nussbaum, R.L. and Usdin, K. (2007) Regional FMRP deficits and large repeat expansions into the full mutation range in anewFragileXpremutation mouse model. Gene, 395, 125-134.
37. Qin, M., Entezam, A., Usdin, K., Huang, T., Liu, Z.H., Hoffman, G.E. and Smith, C.B. (2011) A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis. Neurobiol. Dis., 42, 85-98.
38. Willemsen, R., Hoogeveen-Westerveld, M., Reis, S., Holstege, J., Severijnen, L.A., Nieuwenhuizen, I.M., Schrier, M., van Unen, L., Tassone, F., Hoogeveen, A.T. et al. (2003) The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum. Mol. Genet., 12, 949-959.
39. Bontekoe, C.J., Bakker, C.E., Nieuwenhuizen, I.M., van der Linde, H., Lans, H., de Lange, D., Hirst, M.C. and Oostra, B.A. (2001) Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum. Mol. Genet., 10, 1693-1699.
40. Hunsaker, M.R., von Leden, R.E., Ta, B.T., Goodrich-Hunsaker, N.J., Arque, G., Kim, K., Willemsen, R. and Berman, R.F. (2011) Motor deficits on a ladder rung task in male and female adolescent and adultCGGknock-in mice. Behav. Brain Res., 222, 117-121.
41. Van Dam, D., Errijgers, V., Kooy, R.F., Willemsen, R., Mientjes, E., Oostra, B.A. and De Deyn, P.P. (2005) Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ ataxia syndrome (FXTAS). Behav. Brain Res., 162, 233-239.
42. Diep, A.A., Hunsaker, M.R., Kwock, R., Kim, K., Willemsen, R. and Berman, R.F. (2012) Female CGG knock-in mice modeling the fragile X premutation are impaired on a skilled forelimb reaching task. Neurobiol. Learn. Mem., 97, 229-234.
43. Hunsaker, M.R., Goodrich-Hunsaker, N.J., Willemsen, R. and Berman, R.F. (2010) Temporal ordering deficits in female CGG KI mice heterozygous for the fragile X premutation. Behav. Brain Res., 213, 263-268.
44. Hunsaker, M.R., Wenzel, H.J., Willemsen, R. and Berman, R.F. (2009) Progressive spatial processing deficits in a mouse model of the fragile X premutation. Behav. Neurosci., 123, 1315-1324.
45. Berman, R.F. and Willemsen, R. (2009) Mouse models of fragile X-associated tremor ataxia. J. Investig. Med., 57, 837-841.
46. Chen, Y., Tassone, F., Berman, R.F., Hagerman, P.J., Hagerman, R.J., Willemsen, R. and Pessah, I.N. (2010) Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum. Mol. Genet., 19, 196-208.
47. Lessard, M., Chouiali, A., Drouin, R., Sebire, G. and Corbin, F. (2012) Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome. Clin. Genet., 82, 472-477.
48. Ericsson, C. and Nister, M. (2011) Protein extraction from solid tissue. Methods Mol. Biol., 675, 307-312.
49. Saffary, R. and Xie, Z. (2011)FMRPregulates the transition from radial glial cells to intermediate progenitor cells during neocortical development. J. Neurosci., 31, 1427-1439.
50. Tassone, F., Hagerman, R.J., Garcia-Arocena, D., Khandjian, E.W., Greco, C.M. and Hagerman, P.J. (2004) Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J. Med. Genet., 41, e43.
51. Chen, L.S., Tassone, F., Sahota, P. and Hagerman, P.J. (2003) The (CGG)n repeat element within the 5 ' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum. Mol. Genet., 12, 3067-3074.
52. Ludwig, A.L., Hershey, J.W. and Hagerman, P.J. (2011) Initiation of translation of the FMR1 mRNA Occurs predominantly through 5'-end-dependent ribosomal scanning. J. Mol. Biol., 407, 21-34.
53. Abitbol,M.,Menini,C., Delezoide, A.L.,Rhyner, T.,Vekemans,M.andMallet, J. (1993) Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat. Genet., 4, 147-153.
54. Hinds,H.L.,Ashley,C.T.,Sutcliffe, J.S.,Nelson,D.L.,Warren,S.T.,Housman, D.E. and Schalling, M. (1993) Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat. Genet., 3, 36-43.
55. Bachner, D., Manca, A., Steinbach, P., Wohrle, D., Just, W., Vogel, W., Hameister, H. and Poustka, A. (1993) Enhanced expression of the murine FMR1gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum. Mol. Genet., 2, 2043-2050.
56. Khandjian, E.W., Fortin, A., Thibodeau, A., Tremblay, S., Cote, F., Devys, D., Mandel, J.L. and Rousseau, F. (1995) A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum. Mol. Genet., 4, 783-789.
57. Wang, J.Y., Hessl, D., Iwahashi, C., Cheung, K., Schneider, A., Hagerman, R.J., Hagerman, P.J. and Rivera, S.M. (2013) Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles. Neuroimage, 65, 288-298.
58. Luo, Y., Shan, G., Guo, W., Smrt, R.D., Johnson, E.B., Li, X., Pfeiffer, R.L., Szulwach, K.E., Duan, R., Barkho, B.Z. et al.. (2010) Fragile X mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genet., 6, e1000898.
59. Tassone, F., Hagerman, R.J., Loesch, D.Z., Lachiewicz, A., Taylor, A.K. and Hagerman, P.J. (2000) Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am. J. Med. Genet., 94, 232-236.
60. Tassone, F. and Hagerman, P.J. (2003) Expression of the FMR1 gene. Cytogenet. Genome Res., 100, 124-128.
61. Hunsaker, M.R., Greco, C.M., Tassone, F., Berman, R.F., Willemsen, R., Hagerman, R.J. and Hagerman, P.J. (2011) Rare intranuclear inclusions in the brains of3 older adult males with fragileXsyndrome: implications for the spectrum of fragile X-associated disorders. J. Neuropathol. Exp. Neurol., 70, 462-469.
62. Wenzel,H.J., Hunsaker,M.R., Greco, C.M.,Willemsen,R. andBerman, R.F. (2010) Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation. Brain Res., 1318, 155-166.
63. Greco, C.M., Berman, R.F., Martin, R.M., Tassone, F., Schwartz, P.H., Chang, A., Trapp, B.D., Iwahashi, C., Brunberg, J., Grigsby, J. et al. (2006) Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain, 129, 243-255.
64. Saluto, A., Brussino, A., Tassone, F., Arduino, C., Cagnoli, C., Pappi, P., Hagerman, P., Migone, N. and Brusco, A. (2005) An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J. Mol. Diagn., 7, 605-612.
65. Laemmli, U.K. and Favre, M. (1973) Maturation of the head of bacteriophage T4. I. DNA packaging events. J. Mol. Biol., 80, 575-599.
66. Iwahashi, C., Tassone, F., Hagerman, R.J., Yasui, D., Parrott, G., Nguyen, D., Mayeur, G. and Hagerman, P.J. (2009) A quantitative ELISA assay for the fragile X mental retardation 1 protein. J. Mol. Diagn., 11, 281-289.
67. Rasband, W.S. (1997-2012) ImageJ. U. S. National Institutes of Health, Bethesda, Maryland, USA.